Health Department

Posted on: July 10, 2017

07/10/17-PA HAN 381 - Patients Receiving Eculizumab at High Risk for Invasive Meningococcal Disease

The Pennsylvania Department of Health is forwarding the following advisory to healthcare providers, “Patients Receiving Eculizumab (Soliris®) at High Risk for Invasive Meningococcal Disease Despite Vaccination”

Read on...